Brent Sabatini is CAO & VP at Vir Biotechnology, Inc. (VIR). They have made 2 open-market trades across 1 company since 2025, most recently 2026-06-01.
CIK 0002037272
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIR | 61,902 | $617K |
Shares reported on the most recent Form 4, priced at the 2026-06-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $9.45 | $4K | -1.9% | +14.5% | +24.7% |
| VIR | SELL · 10b5-1 | 2026-03-23 | 2026-03-24 | $9.12 | $70K | +3.4% | +18.2% | +9.1% |
| VIR | SELL · 10b5-1 | 2026-02-24 | 2026-02-26 | $9.53 | $14K | +6.4% | -8.9% | -2.2% |
| VIR | SELL · 10b5-1 | 2026-02-23 | 2026-02-24 | $7.45 | $14K | -2.7% | -8.8% | -4.4% |
| VIR | SELL · 10b5-1 | 2026-02-13 | 2026-02-18 | $7.79 | $12K | +20.7% | +17.6% | +10.1% |
| VIR | SELL | 2025-02-24 | 2025-02-25 | $9.45 | $15K | -11.8% | -26.1% | -48.4% |
| VIR | SELL | 2025-02-13 | 2025-02-14 | $9.15 | $14K | -15.7% | -27.2% | -52.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.